Body mass index as a possible predictor of the development of immuno-mediated adverse events against the background of therapy with inhibitors of immune response control points

A. A. Glibka; N. V. Mazurina; E. A. Troshina; K. A. Sarantseva; G. Yu. Harkevich; M. V. Volkonsky; A. R. Elfimova

doi:10.14341/serg12856-10053

For citations:

Glibka A.A., Mazurina N.V., Troshina E.A., Sarantseva K.A., Harkevich G.Yu., Volkonsky M.V., Elfimova A.R. Body mass index as a possible predictor of the development of immuno-mediated adverse events against the background of therapy with inhibitors of immune response control points. Endocrine Surgery. 2023;17(4):33. (In Russ.) https://doi.org/10.14341/serg12856

Views PDF (Rus): 110

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).

ISSN 2306-3513 (Print)
ISSN 2310-3965 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Endocrine Surgery

For citations:

Cookies policy